The Combination of the PARP Inhibitor Rucaparib and 5FU Is an Effective Strategy for Treating Acute LeukemiasMaria Vittoria Verga Falzacappa, Pier Giuseppe Pelicci, Chiara Ronchini et al.|Molecular Cancer Therapeutics|2015Cited by 29
Data from The Combination of the PARP Inhibitor Rucaparib and 5FU Is an Effective Strategy for Treating Acute LeukemiasMaria Vittoria Verga Falzacappa, Pier Giuseppe Pelicci, Chiara Ronchini et al.|Unknown|2023Cited by 0
Supplementary Figures S1-S4 from The Combination of the PARP Inhibitor Rucaparib and 5FU Is an Effective Strategy for Treating Acute LeukemiasMaria Vittoria Verga Falzacappa, Pier Giuseppe Pelicci, Chiara Ronchini et al.|Unknown|2023Cited by 0
Supplementary Figures S1-S4 from The Combination of the PARP Inhibitor Rucaparib and 5FU Is an Effective Strategy for Treating Acute LeukemiasMaria Vittoria Verga Falzacappa, Pier Giuseppe Pelicci, Chiara Ronchini et al.|Unknown|2023Cited by 0
Data from The Combination of the PARP Inhibitor Rucaparib and 5FU Is an Effective Strategy for Treating Acute LeukemiasMaria Vittoria Verga Falzacappa, Pier Giuseppe Pelicci, Chiara Ronchini et al.|Unknown|2023Cited by 0